Free Trial

Forte Biosciences (FBRX) SEC Filings & 10K Form

Forte Biosciences logo
$15.89 -0.07 (-0.44%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$15.89 0.00 (0.00%)
As of 01/31/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Forte Biosciences SEC Filings

DateFilerForm TypeView
01/24/2025
3:33 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:13 PM
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Oliveira Steven Michael (Filed by)
Form SCHEDULE 13G
01/02/2025
4:10 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:10 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form DEF 14A
12/22/2024
11:15 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form EFFECT
12/20/2024
3:21 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 424B3
12/13/2024
3:36 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/03/2024
3:31 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
4:45 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:02 PM
ALGER ASSOCIATES INC (Filed by)
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Form SC 13G/A
10/02/2024
5:19 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:21 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:50 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
5:26 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
VINCENT RICHARD G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2024
5:28 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Kapoor Shivpreet Singh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2024
5:30 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
VINCENT RICHARD G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
5:31 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Kapoor Shivpreet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:05 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:06 PM
Brun Scott C. (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:07 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Williams Donald Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:08 PM
FINCK BARBARA K (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:09 PM
Doberstein Stephen K (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:10 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Kornfeld Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:11 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
GRYSKA DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:12 PM
Eichenfield Lawrence (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:37 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:02 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form ARS
07/19/2024
3:10 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form PRE 14A
07/03/2024
11:17 AM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
11:18 AM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:24 AM
Camac Fund, LP (Filed by)
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Form SC 13D/A
04/29/2024
4:22 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 10-K/A
04/02/2024
5:31 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:32 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:07 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:08 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:09 PM
FINCK BARBARA K (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:16 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K/A
02/14/2024
3:54 PM
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
TYBOURNE CAPITAL MANAGEMENT LTD (0001553936) (Filed by)
Form SC 13G
02/14/2024
3:56 PM
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
Is this Elon’s true agenda? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

02/14/2024
8:33 AM
Farallon Capital Partners, L.P. (Filed by)
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FBRX) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners